News & media services

More people can be saved from heart attacks

The express intention of Stefan James and his research team is to contribute to improved medical treatment.

Swedish coronary care has attained the highest international standards and is in a good position to take the lead in future developments. So says Stefan James, recently appointed professor of Cardiology at Uppsala University.

“Every year, seven million people die as a result of heart attacks  making it the most common international cause of death. With better methods for early discovery, diagnostics and treatment, many more could be saved,” says Stefan James, who was recently made professor of Cardiology specialising in clinical cardiovascular research.

Stefan James was also recently ranked in the the top one percent of the world’s most quoted researchers in clinical medicine.

“Nine out of ten risk factors for heart attacks are life-style related. Better diet, more exercise and reduced stress are effective ways of preventing cardiovascular diseases. The first important contribution we can all make to encourage our children to choose healthy habits,” says Stefan James.

Unfortunately, heart attacks will most probably continue to torment society and individuals. Stefan James and his research team have the express aim of contributing to improved medical treatment. One way they have achieved this is by studying the results of Swedish coronary care.

“We studied and ranked the outcomes of the care measures carried out at Swedish hospitals  and published our figures. This in itself led to discussions but it also fulfilled its purpose. When we followed it up ten years later, Swedish coronary care had achieved top international standards,” says Stefan James.

Stefan James’ pioneering methods for researching medical records gained great  international attention.

“It is good to see the great interest in cardiovascular research. This is also shown by how many research grants can be applied for. If we can also improve our collaboration with industry, pre-clinical research and international partners, then Sweden will be in a good position to lead developments in this field,” says Stefan James to sum up.

2016-04-26